Earnings Call Announcement

Jubilant Ingrevia Ltd will host an investor conference call on May 26, 2026, to discuss its audited financial results for the quarter and full fiscal year ended March 31, 2026. The company previously reported ₹5,578 crore in revenue and ₹675 crore in profit for the full fiscal year 2025.

Why the Call Matters to Investors

The call is a key opportunity for Jubilant Ingrevia to present its financial performance and provide management's perspective to investors. Attendees can expect details on operational efficiency, segment performance, and strategic moves. Management's commentary on the future outlook, market conditions, and guidance for the next fiscal year will be closely watched.

About Jubilant Ingrevia

Jubilant Ingrevia Ltd is a global integrated provider of Life Science products and innovative solutions. The company's operations span three core segments: Speciality Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. Its product range includes pyridine & picolines, vitamins, acetic acid, and ethyl acetate, serving industries such as pharmaceuticals, agrochemicals, and various industrial applications.

Key Risks to Monitor

Jubilant Ingrevia faces a CGST order for ₹6.63 crore related to FY 2020-21, concerning alleged improper use of input tax credit and a 10% penalty. The company considers the order legally flawed and intends to appeal.

Competitive Landscape

Jubilant Ingrevia competes in the specialty chemicals, nutrition, and chemical intermediates markets. Key competitors include Navin Fluorine International, Alkyl Amines Chemicals, Balaji Amines, and Aarti Industries.

Recent Financial Performance

• In Q3 FY26, Jubilant Ingrevia reported consolidated revenue of ₹1,476 crore and a profit of ₹180 crore.
• For the full fiscal year FY25, the company posted consolidated revenue of ₹5,578 crore and a profit of ₹675 crore.

What Investors Will Watch

Investors will focus on management's commentary on Q4 FY26 and full-year FY26 performance. Key metrics to track include segment revenue growth, earnings before interest, taxes, depreciation, and amortization (EBITDA) margins, and updates on new products or capacity expansions. Guidance for FY27, the outlook for raw material prices, and the competitive environment will also be important. Any updates on legal matters, like the CGST order, should also be noted.